Medpace Holdings [MEDP] vs Thermo Fisher [TMO] Detailed Stock Comparison

Medpace Holdings Inc.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Medpace Holdings Inc. wins in 10 metrics, Thermo Fisher Scientific Inc. wins in 9 metrics, with 0 ties. Medpace Holdings Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medpace Holdings Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 26.90 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 25.37 3.31 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio 20.43 82.91 Medpace Holdings Inc.
PEG Ratio 1.75 2.29 Medpace Holdings Inc.
EV/EBITDA 18.94 19.02 Medpace Holdings Inc.
Profit Margin (TTM) 17.19% 15.15% Medpace Holdings Inc.
Operating Margin (TTM) 20.03% 17.89% Medpace Holdings Inc.
EBITDA Margin (TTM) 20.03% 17.89% Medpace Holdings Inc.
Return on Equity 77.25% 13.52% Medpace Holdings Inc.
Return on Assets (TTM) 17.47% 5.00% Medpace Holdings Inc.
Free Cash Flow (TTM) $681.87M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 56.69% 16.53% Medpace Holdings Inc.
Price-to-Sales Ratio (TTM) 4.38 3.86 Thermo Fisher Scientific Inc.
Enterprise Value $11.19B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 4.18 4.75 Medpace Holdings Inc.
Gross Profit Margin (TTM) 27.78% N/A N/A
Revenue per Share (TTM) $94 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $15.26 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.39 0.97 Thermo Fisher Scientific Inc.
Short % of Float 5.30% 1.22% Thermo Fisher Scientific Inc.

Medpace Holdings Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

MEDP
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings Inc.0.03%2.10%12.58%3.06%-16.39%-18.13%
Thermo Fisher Scientific Inc.0.93%0.87%8.07%0.79%-17.74%-20.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings Inc.56.69%110.68%163.23%1,566.69%1,566.69%1,566.69%
Thermo Fisher Scientific Inc.16.53%-12.65%-2.72%220.94%654.32%1,231.84%

Performance & Financial Health Analysis: Medpace Holdings Inc. vs Thermo Fisher Scientific Inc.

MetricMEDPTMO
Market Information
Market Cap i$11.72B$174.55B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i574,9122,356,220
90 Day Avg. Volume i396,3542,071,517
Last Close$467.50$473.72
52 Week Range$294.07 - $628.92$385.46 - $643.99
% from 52W High-25.67%-26.44%
All-Time High$628.92 (Jan 16, 2026)$672.34 (Dec 27, 2021)
% from All-Time High-25.67%-29.54%
Growth Metrics
Quarterly Revenue Growth0.27%0.06%
Quarterly Earnings Growth0.08%0.10%
Financial Health
Profit Margin (TTM) i0.17%0.15%
Operating Margin (TTM) i0.20%0.18%
Return on Equity (TTM) i0.77%0.14%
Debt to Equity (MRQ) i20.4382.91
Cash & Liquidity
Book Value per Share (MRQ)$16.18$141.96
Cash per Share (MRQ)$22.85$8.75
Operating Cash Flow (TTM) i$739.17M$8.29B
Levered Free Cash Flow (TTM) i$514.58M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Medpace Holdings Inc. vs Thermo Fisher Scientific Inc.

MetricMEDP (Apr 26, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i26.9025.84
Forward P/E i21.9717.16
PEG Ratio i1.752.29
Price to Sales (TTM) i4.383.86
Price to Book (MRQ) i25.373.31
Market Capitalization
Market Capitalization i$11.72B$174.55B
Enterprise Value i$11.19B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i4.184.75
Enterprise to EBITDA i18.9419.02
Risk & Other Metrics
Beta i1.390.97
Book Value per Share (MRQ) i$16.18$141.96

Financial Statements Comparison: Medpace Holdings Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMEDP (2025)TMO (2025)
Revenue/Sales i2.53B44.56B
Cost of Goods Sold i1.77B26.32B
COGS % of Revenue i69.9%59.1%
Gross Profit i760.62M18.24B
Gross Margin i30.1%40.9%
Research & Development iN/A1.40B
Operating Income (EBIT) i534.94M8.11B
Operating Margin i21.1%18.2%
EBITDA i570.79M11.86B
EBITDA Margin i22.6%26.6%
Pre-Tax Income i542.38M7.31B
Pre-Tax Income % of Revenue i21.4%16.4%
Income Tax i91.25M547.00M
Income Tax % of Revenue i3.6%1.2%
Net Income (Profit) i451.12M6.72B
Profit Margin i17.8%15.1%

Balance Sheet & Liquidity Metrics

MetricMEDP (2025)TMO (2025)
Cash & Equivalents i497.05M9.85B
Total Current Assets i989.62M28.71B
Total Current Assets % of Revenue i39.1%64.4%
Total Current Liabilities i1.34B15.19B
Total Current Liabilities % of Revenue i53.1%34.1%
Long-Term Debt i113.64M35.85B
Long-Term Debt % of Revenue i4.5%80.5%
Total Shareholders Equity i459.07M53.54B
Retained Earnings i-459.98M59.16B
Retained Earnings % of Revenue i-18.2%132.8%
Property, Plant & Equipment i171.17M0

Cash Flow Statement Comparison

MetricMEDP (2025)TMO (2025)
Operating Cash Flow i643.24M7.82B
Operating Cash Flow % of Revenue i25.4%17.5%
Capital Expenditures i-31.36M-1.48B
Free Cash Flow i681.87M6.29B
FCF Margin i26.9%14.1%
Debt Repayment i0-3.51B
Common Stock Repurchase i-917.39M-3.00B

Short Interest & Institutional Ownership Analysis

MetricMEDPTMO
Shares Short i1.22M4.54M
Short Ratio i3.932.38
Short % of Float i5.30%1.22%
Shares Outstanding i28.56M371.62M
Float Shares i23.01M371.07M
% Held by Insiders i19.39%0.17%
% Held by Institutions i86.88%95.23%
% Held by Public i-6.27%4.60%

Dividend Analysis & Yield Comparison: Medpace Holdings Inc. vs Thermo Fisher Scientific Inc.

MetricMEDPTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026